the rates of fatal and nonfatal stroke at three years were 10 percent for ticlopidine and 13 percent for aspirin -- a 21 percent risk reduction ( 95 percent confidence interval , 4 to 38 percent ) with ticlopidine ( p = 0.024 for cumulative kaplan-meier estimates ) .
C0038454
stroke
C0040207
ticlopidine